The IRE treatment was during the first week of April, conducted in 2008 as part of a pilot study on the success of the treatment of soft tissue focused with IRE. Biopsies from the treated patients were withdrawn prostate normal and the patient had no side effects erections . The trial is expected to continue to develop clinical data on therapeutic efficacy of the technology. We are very pleased with the early clinical results in human consumption reaches satisfied, commented Dr. Gary Onik MD, President of Oncobionic Inc. And Director of Surgical Imaging at Celebration Health Florida Hospital. This confirms our belief in the value become the technology and its promise to the next generation of ablation technology. In October 2006s a non-thermal tissue ablation technique, which uses electrical fields to nanoscale defects in a cell membrane, which causes cell death in the target tissue in the target tissue, without destroying critical structures such as ducts, blood vessels and nerves An. Research team headed by Boris Rubinsky, Distinguished Professor of Bioengineering at the University of California, Berkeley IRE IRE technology invented in this study used the technology is exclusively from the University of California to Oncobionic for commercial development for commercial development. In addition to smaller incisions the patient benefits are fewer side effects and complications, less pain, less risk of infection and faster recovery.###Poston Harry, has earned a renowned reputation for his work in this area, and has a prestigious NIH research advance scientific understanding and identify the advantages of minimally invasive bypass surgery at BMC.
Governor O’Malley celebrated to least $ 200 million in the in stem cell research investment over ten years, and include stem cell research is as a priority in the Bio2020 initiative of announced this past summer. Maryland is home to a of the three biggest stem cell funds throughout the United States, and unlike many of the other, the money goes directly to research laboratories, these institutions help you drive the potential for for life-saving solutions. FY09 funding for the Maryland Stem Cell Research Fund of has $ 18 million.